Literature DB >> 22977506

Effects of peripherally administered urocortin 3 on feeding behavior and gastric emptying in mice.

Mutsumi Terashi1, Akihiro Asakawa, Kai-Chun Cheng, Ken-Ichiro Koyama, Huke Chaolu, Miharu Ushikai, Akio Inui.   

Abstract

Human and mouse urocortin 3 (Ucn3) were first identified in 2001. Ucn3 binds selectively to corticotropin-releasing factor receptor type 2 (CRF-R2). Previous studies have shown that centrally administered Ucn3 decreases food intake in rats. However, the role of Ucn3 in the regulation of gut motility remains to be determined. In the present study, we investigated the effects of peripherally administered Ucn3 on food intake and gastric emptying in mice. After intraperitoneal (i.p.) administration of Ucn3, food intake was measured in the light and dark phases, and the rate of gastric emptying was determined. We found that i.p. administration of Ucn3 significantly inhibited feeding behavior in mice, and significantly delayed gastric emptying 1-2 h after administration in a dose-dependent manner. These results suggest that Ucn3 contributes to the modulation of feeding behavior and gut motility. Thus, Ucn3 and CRF-R2 may be involved in the pathogenesis of functional gastrointestinal and eating disorders.

Entities:  

Year:  2011        PMID: 22977506      PMCID: PMC3440667          DOI: 10.3892/etm.2011.200

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  22 in total

1.  Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor.

Authors:  S Y Hsu; A J Hsueh
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

2.  Expression cloning of a human corticotropin-releasing-factor receptor.

Authors:  R Chen; K A Lewis; M H Perrin; W W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

3.  Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.

Authors:  K Lewis; C Li; M H Perrin; A Blount; K Kunitake; C Donaldson; J Vaughan; T M Reyes; J Gulyas; W Fischer; L Bilezikjian; J Rivier; P E Sawchenko; W W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

4.  Obesity, overeating, and rapid gastric emptying in rats with ventromedial hypothalamic lesions.

Authors:  J P Duggan; D A Booth
Journal:  Science       Date:  1986-02-07       Impact factor: 47.728

5.  Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.

Authors:  T W Lovenberg; C W Liaw; D E Grigoriadis; W Clevenger; D T Chalmers; E B De Souza; T Oltersdorf
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

6.  Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.

Authors:  W Vale; J Spiess; C Rivier; J Rivier
Journal:  Science       Date:  1981-09-18       Impact factor: 47.728

7.  Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors.

Authors:  T M Reyes; K Lewis; M H Perrin; K S Kunitake; J Vaughan; C A Arias; J B Hogenesch; J Gulyas; J Rivier; W W Vale; P E Sawchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

8.  Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary.

Authors:  E Potter; S Sutton; C Donaldson; R Chen; M Perrin; K Lewis; P E Sawchenko; W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

9.  Comparison of the anorexigenic activity of CRF family peptides.

Authors:  Chie Tanaka; Akihiro Asakawa; Miharu Ushikai; Takeo Sakoguchi; Haruka Amitani; Mutsumi Terashi; KaiChun Cheng; Huhe Chaolu; Norifumi Nakamura; Akio Inui
Journal:  Biochem Biophys Res Commun       Date:  2009-10-20       Impact factor: 3.575

10.  Urocortins and cholecystokinin-8 act synergistically to increase satiation in lean but not obese mice: involvement of corticotropin-releasing factor receptor-2 pathway.

Authors:  G Gourcerol; L Wang; Y H Wang; M Million; Y Taché
Journal:  Endocrinology       Date:  2007-10-11       Impact factor: 4.736

View more
  3 in total

1.  Urocortin 3 expression at baseline and during inflammation in the colon: corticotropin releasing factor receptors cross-talk.

Authors:  Shilpi Mahajan; Min Liao; Paris Barkan; Kazuhiro Takahashi; Aditi Bhargava
Journal:  Peptides       Date:  2014-01-22       Impact factor: 3.750

Review 2.  Gut-Brain Neuroendocrine Signaling Under Conditions of Stress-Focus on Food Intake-Regulatory Mediators.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-28       Impact factor: 5.555

3.  Opposing roles of the entero-pancreatic hormone urocortin-3 in glucose metabolism in rats.

Authors:  Kaare V Grunddal; Samuel A J Trammell; Cecilie Bæch-Laursen; Daniel B Andersen; Stella F S Xu; Helle Andersen; Matthew P Gillum; Seyed M Ghiasi; Ivana Novak; Björn Tyrberg; Chien Li; Mette M Rosenkilde; Bolette Hartmann; Jens J Holst; Rune E Kuhre
Journal:  Diabetologia       Date:  2022-03-24       Impact factor: 10.460

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.